Follow-up in community pharmacy should be routine,not extraordinary

Public Health Agency of Canada. Canadian chronic disease indicators, quick stats, 2017 edition. Available: https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-37-no-8-2017/at-a-glance-2017-canadian-chronic-disease-indicators.html (accessed Jan. 3, 2018).

Reid R Haggerty J McKendry R. Defusing the confusion: concepts and measures of continuity of healthcare. Available: www.cfhi-fcass.ca/Migrated/PDF/ResearchReports/CommissionedResearch/cr_contcare_e.pdf (accessed Jan. 3, 2018).

American Society of Health-System Pharmacists. Continuity of care in medication management: review of issues and considerations for pharmacy. Am J Health Syst Pharm 2005;62:1714-20.

Canadian Institute for Health Information. Pharmacists in Canada, 2015. Available: https://secure.cihi.ca/estore/productFamily.htm?pf=PFC3363&lang=en&media=0 (accessed Jan. 3, 2018).

Canadian Pharmacists Association. Pharmacy in Canada, 2016. Available: www.pharmacists.ca/cpha-ca/assets/File/pharmacy-in-canada/Pharmacy%20in%20Canada.pdf (accessed Jan. 3, 2018).

Shiu JR Simpson SH Johnson JA Tsuyuki RT. Quantifying opportunities to affect diabetes management in the community. Can Pharm J (Ott) 2006;139:37-8.

MacCallum L Consiglio G MacKeigan L Dolovich L. Uptake of community pharmacist-delivered MedsCheck diabetes medication review service in Ontario between 2010 and 2014. Can J Diabetes 2017;41:253-8.

Dolovich L Consiglio G MacKeigan L et al . Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013. Can Pharm J (Ott) 2016;149(5):293-302.

Cipolle RJ Strand LM Morley PC. Follow-up evaluation. In: Pharmaceutical care practice: the patient centered approach to medication management. 3rd ed. Minneapolis (MN): McGraw-Hill; 2012; 265-94.

Ministry of Health and Long-term Care. MedsCheck: Medscheck program for Ontarians living with diabetes. Available: www.health.gov.on.ca/en/pro/programs/drugs/medscheck/medscheck_diabetes.aspx (accessed Jan. 3, 2018).

Al Hamarneh YN Charrois T Lewanczuk R Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open 2013;3:e003154. doi: 10.1136/bmjopen-2013-003154.

Tsuyuki RT Al Hamarneh YN Jones CA Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicentre randomized controlled RxEACH trial. J Am Coll Cardiol 2016;67(24):2846-54. doi: 10.1016/j.jacc.2016.03.528.

McLean DL McAlister FA Johnson JA et al . A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med 2008;168(21):2355-61. doi: 10.1001/archinte.168.21.2355.

Pousinho S Morgado M Falcão A Alves G. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm 2016;22(5):493-515. doi: 10.18553/jmcp.2016.22.5.493.

Al Hamarneh YN Sauriol L Tsuyuki RT. After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study. BMJ Open 2015;5:e008152. doi: 10.1136/bmjopen-2015-008152.

Shatnawi A Latif DA. A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management. J Eval Clin Pract 2017;23(3):586-92. doi: 10.1111/jep.12677.

Penm J Jorgenson D MacKinnon NJ Smith J. Part 1: barriers to the advancement of the pharmacy profession. Can Pharm J (Ott) 2017;150(3):150-2. doi: 10.1177/1715163517702377.

MacKeigan LD Ijaz N Bojarski EA Dolovich L. Implementation of a reimbursed medication review program: corporate and pharmacy level strategies. Res Social Adm Pharm 2017;13(5):947-58. doi.org/10.1016/j.sapharm.2017.03.057